Beneficial effect of intravenous iron, ferric carboxymaltose, in heart failure

被引：0
|
作者：
Paterek, A. [1 ]
Kolodziejczyk, J. [1 ]
Kepska, M. [1 ]
Mackiewicz, U. [1 ]
Maczewski, M. [1 ]
机构：
[1] Med Ctr Postgrad Educ, Dept Clin Physiol, Warsaw, Poland
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1966
引用
收藏
页码：512 / 512
页数：1
相关论文
共 50 条
  • [21] Experience with intravenous ferric carboxymaltose in patients with iron deficiency anemia
    Bregman, David B.
    Goodnough, Lawrence T.
    [J]. THERAPEUTIC ADVANCES IN HEMATOLOGY, 2014, 5 (02) : 48 - 60
  • [22] Safety and Efficacy of Ferric Carboxymaltose in Heart Failure With Preserved Ejection Fraction and Iron Deficiency
    Shabeer, Hassan
    Samore, Naseer
    Ahsan, Salman
    Gondal, Muhammad Umer Riaz
    Shah, Badar U. Din
    Ashraf, Amna
    Faraz, Maria
    Malik, Jahanzeb
    [J]. CURRENT PROBLEMS IN CARDIOLOGY, 2024, 49 (01)
  • [23] Hypophosphatemia After Intravenous Ferric Carboxymaltose in Heart Transplant Patients
    Santulario-Verdu, L.
    Echeverry-Navarrete, E.
    Diez-Lopez, C.
    Canedo-Castelo, M.
    Juvany-Roig, R.
    Garcia-Romero, E.
    Roca-Elias, J.
    Manito-Lorite, N.
    Gonzalez-Costello, J.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S220 - S221
  • [24] Potential role of empagliflozin in myocardial iron repletion following ferric carboxymaltose for heart failure
    Lorenzo, Miguel
    de la Espriella, Rafael
    Cardells, Ingrid
    Gorriz, Joso Luis
    Bayes-Genis, Antoni
    Nunez, Julio
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2023, 76 (02): : 121 - 123
  • [25] Budget Impact of Intravenous Iron Therapy with Ferric Carboxymaltose in Patients with Chronic Heart Failure with Reduced Ejection Fraction (HFrEF) and Iron Deficiency in Switzerland
    Elisabeth Brock
    Giorgio Moschovitis
    Micha T. Maeder
    Otmar Pfister
    [J]. PharmacoEconomics - Open, 2022, 6 : 735 - 743
  • [26] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Bernd Froessler
    Tijana Gajic
    Gustaaf Dekker
    Nicolette A. Hodyl
    [J]. Archives of Gynecology and Obstetrics, 2018, 298 : 75 - 82
  • [27] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Ibrahim A. Abdelazim
    Bassam Nusair
    Shikanova Svetlana
    Gulmira Zhurabekova
    [J]. Archives of Gynecology and Obstetrics, 2018, 298 : 1231 - 1232
  • [28] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Abdelazim, Ibrahim A.
    Nusair, Bassam
    Svetlana, Shikanova
    Zhurabekova, Gulmira
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (06) : 1231 - 1232
  • [29] Treatment of iron deficiency and iron deficiency anemia with intravenous ferric carboxymaltose in pregnancy
    Froessler, Bernd
    Gajic, Tijana
    Dekker, Gustaaf
    Hodyl, Nicolette A.
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2018, 298 (01) : 75 - 82
  • [30] Efficacy of intravenous ferric carboxymaltose in patients with acute heart failure and iron deficiency with and without anaemia: a subgroup analysis of AFFIRM-AHF
    Filippatos, G.
    Ponikowski, P.
    Farmakis, D.
    Metra, M.
    Ruschitzka, F.
    Van der Meer, P.
    Kirwan, B. -A.
    MacDougall, I. C.
    Fabien, V.
    Waechter, S.
    Butler, J.
    Anker, S. D.
    Jankowska, E. A.
    [J]. EUROPEAN HEART JOURNAL, 2021, 42 : 1053 - 1053
12345